These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 28315586

  • 1. Sucralfate versus histamine 2 receptor antagonists for stress ulcer prophylaxis in adult critically ill patients: A meta-analysis and trial sequential analysis of randomized trials.
    Alquraini M, Alshamsi F, Møller MH, Belley-Cote E, Almenawer S, Jaeschke R, MacLaren R, Alhazzani W.
    J Crit Care; 2017 Aug; 40():21-30. PubMed ID: 28315586
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials.
    Huang J, Cao Y, Liao C, Wu L, Gao F.
    Crit Care; 2010 Aug; 14(5):R194. PubMed ID: 21034484
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials.
    Wang Y, Ge L, Ye Z, Siemieniuk RA, Reintam Blaser A, Wang X, Perner A, Møller MH, Alhazzani W, Cook D, Guyatt GH.
    Intensive Care Med; 2020 Nov; 46(11):1987-2000. PubMed ID: 32833040
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patients.
    Schumock GT, Lam NP, Winkler SR, Kong SX.
    Pharmacoeconomics; 1996 May; 9(5):455-65. PubMed ID: 10160257
    [Abstract] [Full Text] [Related]

  • 16. Stress ulcer prophylaxis: gastrointestinal bleeding and nosocomial pneumonia. Best evidence synthesis.
    Cook DJ.
    Scand J Gastroenterol Suppl; 1995 May; 210():48-52. PubMed ID: 8578207
    [Abstract] [Full Text] [Related]

  • 17. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
    Reynolds PM, MacLaren R.
    Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
    Sridharan K, Sivaramakrishnan G, Gnanaraj J.
    Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
    He N, Yan Y, Su S, Ge Q, Zhai S.
    Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.